131 related articles for article (PubMed ID: 37403344)
1. Monoclonal gammopathy of unknown significance in kidney transplanted patients: novel insights into long-term outcomes.
Meuleman MS; Mouyabi S; Gueguen J; Vicca S; Divard G; Aubert O; Bienaimé F; Arnulf B; Anglicheau D; Bridoux F; Cohen C
Nephrol Dial Transplant; 2023 Dec; 39(1):64-73. PubMed ID: 37403344
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience.
Alfano G; Fontana F; Colaci E; Messerotti A; Bettelli F; Potenza L; Luppi M; Cappelli G
Transplantation; 2017 Nov; 101(11):e337-e342. PubMed ID: 28731904
[TBL] [Abstract][Full Text] [Related]
3. Monoclonal gammopathy of undetermined significance coexisting in patients undergoing kidney transplantation does not adversely influence post-graft clinical outcome.
Clari R; Tarella C; Giraudi R; Torazza MC; Gallo E; Lavacca A; Fop F; Mella A; Dolla C; Biancone L
Clin Kidney J; 2021 Jan; 14(1):317-324. PubMed ID: 33564434
[TBL] [Abstract][Full Text] [Related]
4. Initial survival data of kidney transplant patients with pre-transplant monoclonal gammopathy.
Soltero L; Carbajal H; Xu J; McCarthy J; Suki WN; Gaber AO; Adrogué HE
Clin Transplant; 2012; 26(2):300-4. PubMed ID: 22044717
[TBL] [Abstract][Full Text] [Related]
5. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
[TBL] [Abstract][Full Text] [Related]
6. Follow-up monoclonal gammopathy of undetermined significance in kidney transplant.
Cuéllar-García C; Sevillano Ruiz-Mateos C; Mazuecos Blanca MA; Narvaez Mejia C; Fernandez Valle MC; Martin Reina V; Gonzalez Bernal M; Yera Cobo M; Rodriguez Lopez R; de Cos Hohr C; Garrastazul MP; Marchante I; Paz Coll A; Capote Huelva FJ
Transplant Proc; 2015; 47(1):78-80. PubMed ID: 25645776
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of Monoclonal Gammopathy of Undetermined Significance in Patients Who Underwent Kidney Transplantation.
Bancu I; Cañas L; Juega FJ; Pérez M; Malumbres S; Bonet J; Lauzurica R
Transplant Proc; 2015 Oct; 47(8):2344-5. PubMed ID: 26518922
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of monoclonal gammopathy of undetermined significance in transplant patients.
Rostaing L; Modesto A; Abbal M; Durand D
Am J Nephrol; 1994; 14(3):187-91. PubMed ID: 7977478
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of monoclonal gammopathies and clinical outcomes in a high-risk US population screened by mass spectrometry: a multicentre cohort study.
El-Khoury H; Lee DJ; Alberge JB; Redd R; Cea-Curry CJ; Perry J; Barr H; Murphy C; Sakrikar D; Barnidge D; Bustoros M; Leblebjian H; Cowan A; Davis MI; Amstutz J; Boehner CJ; Lightbody ED; Sklavenitis-Pistofidis R; Perkins MC; Harding S; Mo CC; Kapoor P; Mikhael J; Borrello IM; Fonseca R; Weiss ST; Karlson E; Trippa L; Rebbeck TR; Getz G; Marinac CR; Ghobrial IM
Lancet Haematol; 2022 May; 9(5):e340-e349. PubMed ID: 35344689
[TBL] [Abstract][Full Text] [Related]
10. Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance.
Kyle RA; Larson DR; Therneau TM; Dispenzieri A; Kumar S; Cerhan JR; Rajkumar SV
N Engl J Med; 2018 Jan; 378(3):241-249. PubMed ID: 29342381
[TBL] [Abstract][Full Text] [Related]
11. Neoplastic and non-neoplastic complications of solid organ transplantation in patients with preexisting monoclonal gammopathy of undetermined significance.
Goebel TE; Schiltz NK; Woodside KJ; Pillai AC; Caimi PF; Lazarus HM; Koroukian SM; Campagnaro EL
Clin Transplant; 2015 Sep; 29(9):851-7. PubMed ID: 26194021
[TBL] [Abstract][Full Text] [Related]
12. [Analysis of serum levels of Dickkopf-1 (DKK-1) in monoclonal gammopathy of undetermined significance and multiple myeloma].
Ščudla V; Petrová P; Pika T; Lochman P; Minařík J; Bačovský J; Srovnalík K
Cas Lek Cesk; 2015; 154(4):181-8. PubMed ID: 26357861
[TBL] [Abstract][Full Text] [Related]
13. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
[TBL] [Abstract][Full Text] [Related]
14. Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma.
Greenberg AJ; Rajkumar SV; Larson DR; Dispenzieri A; Therneau TM; Colby CL; Phelps TK; Kumar SK; Katzmann JA; Kyle RA; Slager SL; Vachon CM
Br J Haematol; 2012 May; 157(4):472-5. PubMed ID: 22629552
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal Gammopathy of Undetermined Significance (MGUS)Monoclonal Gammopathy of Undetermined Significance (MGUS).
Viera S; Ludek P; Zdeněk A; Marta K; Martin Š; Sabina Š; Zdeněk K
Klin Onkol; 2018; 31(4):270-276. PubMed ID: 30541309
[TBL] [Abstract][Full Text] [Related]
16. Secondary monoclonal gammopathy of undetermined significance is frequently associated with high response rate and superior survival in patients with plasma cell dyscrasias.
Zou D; An G; Zhu G; Wang J; Shi L; Meng H; Xu Y; Sui W; Deng S; Zhan F; Qiu L
Biol Blood Marrow Transplant; 2014 Mar; 20(3):319-25. PubMed ID: 24296491
[TBL] [Abstract][Full Text] [Related]
17. Post-MGUS Diagnosis Serum Monoclonal-Protein Velocity and the Progression of Monoclonal Gammopathy of Undetermined Significance to Multiple Myeloma.
Chang SH; Gumbel J; Luo S; Thomas TS; Sanfilippo KM; Luo J; Colditz GA; Carson KR
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2055-2061. PubMed ID: 31501149
[TBL] [Abstract][Full Text] [Related]
18. Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis.
Go RS; Gundrum JD; Neuner JM
Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):177-186.e4. PubMed ID: 25445471
[TBL] [Abstract][Full Text] [Related]
19. Multimorbidity in patients with monoclonal gammopathy of undetermined significance.
Epstein MM; Zhou Y; Castaneda-Avila MA; Cohen HJ
Int J Cancer; 2023 Jun; 152(12):2485-2492. PubMed ID: 36799553
[TBL] [Abstract][Full Text] [Related]
20. Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics.
Greenberg AJ; Rajkumar SV; Vachon CM
Blood; 2012 Jun; 119(23):5359-66. PubMed ID: 22354002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]